(Q33998353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

The management of tumor lysis syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Elvira Rampello

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Tiziana Fricia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Oncology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

438-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

Molecular physiology of urate transport

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

Tumour lysis syndrome, case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

Tumor lysis syndrome: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute spontaneous tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute renal failure from spontaneous acute tumor lysis syndrome: a case report and review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: a case report

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome in nonhematologic malignancies. Report of a case and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome after tamoxifen flare

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome associated with paclitaxel

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome in small cell carcinoma and other solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome in nonhematopoietic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome with metastatic medulloblastoma: A case report

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome after combination chemotherapy for ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome in solid tumors--a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Electrocardiographic manifestations of hyperkalemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Serum phosphate abnormalities in the emergency department

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Emergencies of calcium homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Solubility of uric acid and monosodium urate

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Hyperuricemic Nephropathy: Pathologic Features and Factors Influencing Urate Deposition

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

URIC ACID EXCRETION AND RENAL FUNCTION IN THE ACUTE HYPERURICEMIA OF LEUKEMIA. PATHOGENESIS AND THERAPY OF URIC ACID NEPHROPATHY

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Asystole during combination chemotherapy for non-Hodgkin's lymphoma: the acute tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute renal failure: a practical update

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Tumour lysis syndrome: new therapeutic strategies and classification

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Management of acute tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Purine excretion during tumor lysis in children with acute lymphocytic leukemia receiving allopurinol: relationship to acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Urinary Xanthine Stones-a Rare Complication of Allopurinol Therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

European experience in the treatment of hyperuricemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Serial measurement of renal plasma flow.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute adverse reactions attributed to allopurinol in hospitalised patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Allopurinol hypersensitivity syndrome: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Colonic necrosis following sodium polystyrene sulfonate (Kayexalate)-sorbitol enema in a renal transplant patient. Report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPONC0581

1 reference

7 January 2021

A review of clinical and laboratory findings and treatment of tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Renal function after autologous bone marrow transplantation in children: a long-term prospective study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Acute renal failure in the 21st century: recommendations for management and outcomes assessment

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0581

7 January 2021

Identifiers

DOI

10.1038/NCPONC0581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16894389%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference